https://scholars.lib.ntu.edu.tw/handle/123456789/543493
標題: | Management of gastric cancer in Asia: Resource-stratified guidelines | 作者: | Shen L. Shan Y.-S. Hu H.-M. Price T.J. Sirohi B. KUN-HUEI YEH Yang Y.-H. Sano T. Yang H.-K. Zhang X. Park S.R. Fujii M. Kang Y.-K. Chen L.-T. |
公開日期: | 2013 | 卷: | 14 | 期: | 12 | 起(迄)頁: | e535-e547 | 來源出版物: | The Lancet Oncology | 摘要: | Gastric cancer is the fourth most common cancer globally, and is the second most common cause of death from cancer worldwide. About three-quarters of newly diagnosed cases in 2008 were from Asian countries. With a high mortality-to-incidence ratio, management of gastric cancer is challenging. We discuss evidence for optimum management of gastric cancer in aspects of screening and early detection, diagnosis, and staging; endoscopic and surgical intervention; and the concepts of perioperative, postoperative, and palliative chemotherapy and use of molecularly targeted therapy. Recommendations are formulated on the basis of the framework provided by the Breast Health Global Initiative, using the categories of basic, limited, enhanced, and maximum level. We aim to provide a stepwise strategy for management of gastric cancer applicable to different levels of health-care resources in Asian countries. ? 2013 Elsevier Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84886662730&doi=10.1016%2fS1470-2045%2813%2970436-4&partnerID=40&md5=17bbde384224e43e29e8b2ec61ac2caf https://scholars.lib.ntu.edu.tw/handle/123456789/543493 |
ISSN: | 1470-2045 | DOI: | 10.1016/S1470-2045(13)70436-4 | SDG/關鍵字: | capecitabine; cisplatin; docetaxel; epirubicin; fluoropyrimidine; fluorouracil; folinic acid; gimeracil plus oteracil potassium plus tegafur; irinotecan; lapatinib; oxaliplatin; paclitaxel; panitumumab; ramucirumab; trastuzumab; Asia; cancer incidence; cancer mortality; cancer palliative therapy; cancer radiotherapy; cancer screening; cancer staging; cause of death; China; computer assisted emission tomography; cost effectiveness analysis; digestive tract endoscopy; early diagnosis; endoscopic surgery; gastrectomy; government; health program; Helicobacter infection; human; India; inoperable cancer; Japan; laparoscopy; lymph node dissection; lymphadenopathy; Malaysia; molecularly targeted therapy; Mongolia; nuclear magnetic resonance imaging; Pakistan; perioperative period; postoperative care; practice guideline; prevalence; priority journal; review; Singapore; South Korea; stomach adenocarcinoma; stomach cancer; Taiwan; Thailand; Viet Nam; Antineoplastic Agents; Asia; Chemotherapy, Adjuvant; Delivery of Health Care; Early Detection of Cancer; Gastrectomy; Gastroscopy; Health Resources; Health Services Accessibility; Healthcare Disparities; Humans; Medical Oncology; Molecular Targeted Therapy; Predictive Value of Tests; Stomach Neoplasms; Treatment Outcome |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。